FDA Inspection
S.s.s. Company (international)S.s.s. Company (international) – FDA Inspection, May 27, 2022
Record Details
This FDA Inspection record concerns S.s.s. Company (international), with an inspection on May 27, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- May 27, 2022
- Product Type
- Drugs
View Company Profile
ID · 1116d5ec-eacc-48a4-9584-3e4be1df36f5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1170923
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.125(a)Strict control not exercised over labeling issued
Full citation text and observation details available on the Dashboard.
Other FDA inspections of S.s.s. Company (international)
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 26, 2026 | Not classified | Atlanta District Office | Drug Quality Assurance |
| October 17, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 16, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 31, 2014 | VAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| March 18, 2011 | VAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
Other documents for S.s.s. Company (international)
- FDA Inspection 1324324 - 2026-06-26
- FDA Inspection 1070681 - 2018-10-17
- FDA Inspection 955747 - 2015-12-16
- FDA Inspection 871670 - 2014-03-31
- FDA Inspection 715398 - 2011-03-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.